APO Research
Talk to an analyst

APO RESEARCH · REPORT

Live Cell Encapsulation

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.

Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.

Selected research

Market Analysis & Forecast

Global Live Cell Encapsulation Market Analysis and Forecast 2026-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchLive Cell Encapsulation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Cell Encapsulation Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Live Cell Encapsulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Cell Encapsulation Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Cell Encapsulation Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.

Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.

Read the full market overview

Global Live Cell Encapsulation key players include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.

Report Includes

This report presents an overview of global market for Live Cell Encapsulation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Live Cell Encapsulation, also provides the revenue of main regions and countries. Of the upcoming market potential for Live Cell Encapsulation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Live Cell Encapsulation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Live Cell Encapsulation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Live Cell Encapsulation revenue, projected growth trends, production technology, application and end-user industry.

Live Cell Encapsulation Segment by Company

Viacyte, Inc.

Living Cell Technologies Ltd.

Sigilon Therapeutics, Inc

Sernova Corporation

PharmaCyte Biotech Inc

Gloriana Therapeutics

Kadimastem

Beta-O2 Technologies, Inc.

Altucell, Inc.

Diatranz Otsuka Ltd

Live Cell Encapsulation Segment by Type

Alginate

Chitosan

Cellulose

Others

Live Cell Encapsulation Segment by Application

Diabetes

Cancer

Epilepsy

Parkinson

Others

Live Cell Encapsulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Encapsulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Cell Encapsulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Encapsulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Live Cell Encapsulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Live Cell Encapsulation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live Cell Encapsulation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Live Cell Encapsulation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Alginate Major Player Table 3. Chitosan Major Player Table 4. Cellulose Major Player Table 5. Others Major Player Table 6. Global Live Cell Encapsulation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Diabetes Major Player Table 8. Cancer Major Player Table 9. Epilepsy Major Player Table 10. Parkinson Major Player Table 11. Others Major Player Table 12. Live Cell Encapsulation Industry Trends Table 13. Live Cell Encapsulation Industry Drivers Table 14. Live Cell Encapsulation Industry Opportunities and Challenges Table 15. Live Cell Encapsulation Industry Restraints Table 16. Global Live Cell Encapsulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Live Cell Encapsulation Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Live Cell Encapsulation Market Share by Region (2021-2026) Table 19. Global Live Cell Encapsulation Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Live Cell Encapsulation Market Share by Region (2027-2032) Table 21. Global Live Cell Encapsulation Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Live Cell Encapsulation Revenue Market Share by Players (2021-2026) Table 23. Global Live Cell Encapsulation Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Live Cell Encapsulation Key Players Headquarters & Area Served Table 25. Global Live Cell Encapsulation Players, Product Type & Application Table 26. Global Live Cell Encapsulation Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Live Cell Encapsulation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Live Cell Encapsulation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Live Cell Encapsulation Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Live Cell Encapsulation Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Live Cell Encapsulation Revenue Market Share by Type (2021-2026) Table 33. Global Live Cell Encapsulation Revenue Market Share by Type (2027-2032) Table 34. Global Live Cell Encapsulation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Live Cell Encapsulation Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Live Cell Encapsulation Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Live Cell Encapsulation Revenue Market Share by Application (2021-2026) Table 38. Global Live Cell Encapsulation Revenue Market Share by Application (2027-2032) Table 39. Viacyte, Inc. Company Information Table 40. Viacyte, Inc. Business Overview Table 41. Viacyte, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Viacyte, Inc. Live Cell Encapsulation Product Portfolio Table 43. Viacyte, Inc. Recent Development Table 44. Living Cell Technologies Ltd. Company Information Table 45. Living Cell Technologies Ltd. Business Overview Table 46. Living Cell Technologies Ltd. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio Table 48. Living Cell Technologies Ltd. Recent Development Table 49. Sigilon Therapeutics, Inc Company Information Table 50. Sigilon Therapeutics, Inc Business Overview Table 51. Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio Table 53. Sigilon Therapeutics, Inc Recent Development Table 54. Sernova Corporation Company Information Table 55. Sernova Corporation Business Overview Table 56. Sernova Corporation Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Sernova Corporation Live Cell Encapsulation Product Portfolio Table 58. Sernova Corporation Recent Development Table 59. PharmaCyte Biotech Inc Company Information Table 60. PharmaCyte Biotech Inc Business Overview Table 61. PharmaCyte Biotech Inc Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio Table 63. PharmaCyte Biotech Inc Recent Development Table 64. Gloriana Therapeutics Company Information Table 65. Gloriana Therapeutics Business Overview Table 66. Gloriana Therapeutics Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Gloriana Therapeutics Live Cell Encapsulation Product Portfolio Table 68. Gloriana Therapeutics Recent Development Table 69. Kadimastem Company Information Table 70. Kadimastem Business Overview Table 71. Kadimastem Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Kadimastem Live Cell Encapsulation Product Portfolio Table 73. Kadimastem Recent Development Table 74. Beta-O2 Technologies, Inc. Company Information Table 75. Beta-O2 Technologies, Inc. Business Overview Table 76. Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio Table 78. Beta-O2 Technologies, Inc. Recent Development Table 79. Altucell, Inc. Company Information Table 80. Altucell, Inc. Business Overview Table 81. Altucell, Inc. Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Altucell, Inc. Live Cell Encapsulation Product Portfolio Table 83. Altucell, Inc. Recent Development Table 84. Diatranz Otsuka Ltd Company Information Table 85. Diatranz Otsuka Ltd Business Overview Table 86. Diatranz Otsuka Ltd Live Cell Encapsulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio Table 88. Diatranz Otsuka Ltd Recent Development Table 89. North America Live Cell Encapsulation Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Live Cell Encapsulation Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Live Cell Encapsulation Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Live Cell Encapsulation Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Live Cell Encapsulation Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Live Cell Encapsulation Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Live Cell Encapsulation Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Live Cell Encapsulation Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Live Cell Encapsulation Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Live Cell Encapsulation Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Live Cell Encapsulation Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Live Cell Encapsulation Revenue by Country (US$ Million) & (2027-2032) Table 103. China Live Cell Encapsulation Revenue by Type (2021-2026) & (US$ Million) Table 104. China Live Cell Encapsulation Revenue by Type (2027-2032) & (US$ Million) Table 105. China Live Cell Encapsulation Revenue by Application (2021-2026) & (US$ Million) Table 106. China Live Cell Encapsulation Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Live Cell Encapsulation Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Live Cell Encapsulation Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Live Cell Encapsulation Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Live Cell Encapsulation Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Live Cell Encapsulation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Live Cell Encapsulation Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Live Cell Encapsulation Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Live Cell Encapsulation Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Live Cell Encapsulation Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Live Cell Encapsulation Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Live Cell Encapsulation Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Live Cell Encapsulation Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Live Cell Encapsulation Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Live Cell Encapsulation Image Figure 2. Global Live Cell Encapsulation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Cell Encapsulation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Alginate Image Figure 5. Chitosan Image Figure 6. Cellulose Image Figure 7. Others Image Figure 8. Global Live Cell Encapsulation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Live Cell Encapsulation Market Size Share 2021 VS 2025 VS 2032 Figure 10. Diabetes Image Figure 11. Cancer Image Figure 12. Epilepsy Image Figure 13. Parkinson Image Figure 14. Others Image Figure 15. Global Live Cell Encapsulation Market Size (US$ Million) & (2021-2032) Figure 16. Global Live Cell Encapsulation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Live Cell Encapsulation Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Live Cell Encapsulation Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Live Cell Encapsulation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Live Cell Encapsulation Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Live Cell Encapsulation Revenue Market Share by Type (2021-2032) Figure 23. Global Live Cell Encapsulation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Live Cell Encapsulation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Live Cell Encapsulation Revenue Market Share by Application (2021-2032) Figure 26. North America Live Cell Encapsulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Live Cell Encapsulation Revenue Share by Type (2021-2032) Figure 28. North America Live Cell Encapsulation Revenue Share by Application (2021-2032) Figure 29. North America Live Cell Encapsulation Revenue Share by Country (2021-2032) Figure 30. United States Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Live Cell Encapsulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Live Cell Encapsulation Revenue Share by Type (2021-2032) Figure 35. Europe Live Cell Encapsulation Revenue Share by Application (2021-2032) Figure 36. Europe Live Cell Encapsulation Revenue Share by Country (2021-2032) Figure 37. Germany Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Live Cell Encapsulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Live Cell Encapsulation Revenue Share by Type (2021-2032) Figure 47. China Live Cell Encapsulation Revenue Share by Application (2021-2032) Figure 48. Asia Live Cell Encapsulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Live Cell Encapsulation Revenue Share by Type (2021-2032) Figure 50. Asia Live Cell Encapsulation Revenue Share by Application (2021-2032) Figure 51. Asia Live Cell Encapsulation Revenue Share by Region (2021-2032) Figure 52. Japan Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Live Cell Encapsulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Live Cell Encapsulation Revenue Share by Type (2021-2032) Figure 60. SAMEA Live Cell Encapsulation Revenue Share by Application (2021-2032) Figure 61. SAMEA Live Cell Encapsulation Revenue Share by Country (2021-2032) Figure 62. Brazil Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Live Cell Encapsulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Alginate
  • Chitosan
  • Cellulose
  • Others
Applications
  • Diabetes
  • Cancer
  • Epilepsy
  • Parkinson
  • Others
Companies covered
  • Viacyte, Inc.
  • Living Cell Technologies Ltd.
  • Sigilon Therapeutics, Inc
  • Sernova Corporation
  • PharmaCyte Biotech Inc
  • Gloriana Therapeutics
  • Kadimastem
  • Beta-O2 Technologies, Inc.
  • Altucell, Inc.
  • Diatranz Otsuka Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Live Cell Encapsulation Market by Type
  3. 1.2.1 Global Live Cell Encapsulation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Alginate
  5. 1.2.3 Chitosan
  6. 1.2.4 Cellulose
  7. 1.2.5 Others
  8. 1.3 Live Cell Encapsulation Market by Application
  9. 1.3.1 Global Live Cell Encapsulation Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Diabetes
  11. 1.3.3 Cancer
  12. 1.3.4 Epilepsy
  13. 1.3.5 Parkinson
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Live Cell Encapsulation Market Dynamics
  1. 2.1 Live Cell Encapsulation Industry Trends
  2. 2.2 Live Cell Encapsulation Industry Drivers
  3. 2.3 Live Cell Encapsulation Industry Opportunities and Challenges
  4. 2.4 Live Cell Encapsulation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Live Cell Encapsulation Market Perspective (2021-2032)
  2. 3.2 Global Live Cell Encapsulation Growth Trends by Region
  3. 3.2.1 Global Live Cell Encapsulation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Live Cell Encapsulation Market Size by Region (2021-2026)
  5. 3.2.3 Global Live Cell Encapsulation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Live Cell Encapsulation Revenue by Players
  2. 4.1.1 Global Live Cell Encapsulation Revenue by Players (2021-2026)
  3. 4.1.2 Global Live Cell Encapsulation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Live Cell Encapsulation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Live Cell Encapsulation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Live Cell Encapsulation Key Players Headquarters & Area Served
  7. 4.4 Global Live Cell Encapsulation Players, Product Type & Application
  8. 4.5 Global Live Cell Encapsulation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Live Cell Encapsulation Market CR5 and HHI
  11. 4.6.3 2025 Live Cell Encapsulation Tier 1, Tier 2, and Tier 3
5 Live Cell Encapsulation Market Size by Type
  1. 5.1 Global Live Cell Encapsulation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Live Cell Encapsulation Revenue by Type (2021-2032)
  3. 5.3 Global Live Cell Encapsulation Revenue Market Share by Type (2021-2032)
6 Live Cell Encapsulation Market Size by Application
  1. 6.1 Global Live Cell Encapsulation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Live Cell Encapsulation Revenue by Application (2021-2032)
  3. 6.3 Global Live Cell Encapsulation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Viacyte, Inc.
  2. 7.1.1 Viacyte, Inc. Company Information
  3. 7.1.2 Viacyte, Inc. Business Overview
  4. 7.1.3 Viacyte, Inc. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Viacyte, Inc. Live Cell Encapsulation Product Portfolio
  6. 7.1.5 Viacyte, Inc. Recent Developments
  7. 7.2 Living Cell Technologies Ltd.
  8. 7.2.1 Living Cell Technologies Ltd. Company Information
  9. 7.2.2 Living Cell Technologies Ltd. Business Overview
  10. 7.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio
  12. 7.2.5 Living Cell Technologies Ltd. Recent Developments
  13. 7.3 Sigilon Therapeutics, Inc
  14. 7.3.1 Sigilon Therapeutics, Inc Company Information
  15. 7.3.2 Sigilon Therapeutics, Inc Business Overview
  16. 7.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio
  18. 7.3.5 Sigilon Therapeutics, Inc Recent Developments
  19. 7.4 Sernova Corporation
  20. 7.4.1 Sernova Corporation Company Information
  21. 7.4.2 Sernova Corporation Business Overview
  22. 7.4.3 Sernova Corporation Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sernova Corporation Live Cell Encapsulation Product Portfolio
  24. 7.4.5 Sernova Corporation Recent Developments
  25. 7.5 PharmaCyte Biotech Inc
  26. 7.5.1 PharmaCyte Biotech Inc Company Information
  27. 7.5.2 PharmaCyte Biotech Inc Business Overview
  28. 7.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio
  30. 7.5.5 PharmaCyte Biotech Inc Recent Developments
  31. 7.6 Gloriana Therapeutics
  32. 7.6.1 Gloriana Therapeutics Company Information
  33. 7.6.2 Gloriana Therapeutics Business Overview
  34. 7.6.3 Gloriana Therapeutics Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Gloriana Therapeutics Live Cell Encapsulation Product Portfolio
  36. 7.6.5 Gloriana Therapeutics Recent Developments
  37. 7.7 Kadimastem
  38. 7.7.1 Kadimastem Company Information
  39. 7.7.2 Kadimastem Business Overview
  40. 7.7.3 Kadimastem Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Kadimastem Live Cell Encapsulation Product Portfolio
  42. 7.7.5 Kadimastem Recent Developments
  43. 7.8 Beta-O2 Technologies, Inc.
  44. 7.8.1 Beta-O2 Technologies, Inc. Company Information
  45. 7.8.2 Beta-O2 Technologies, Inc. Business Overview
  46. 7.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio
  48. 7.8.5 Beta-O2 Technologies, Inc. Recent Developments
  49. 7.9 Altucell, Inc.
  50. 7.9.1 Altucell, Inc. Company Information
  51. 7.9.2 Altucell, Inc. Business Overview
  52. 7.9.3 Altucell, Inc. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Altucell, Inc. Live Cell Encapsulation Product Portfolio
  54. 7.9.5 Altucell, Inc. Recent Developments
  55. 7.10 Diatranz Otsuka Ltd
  56. 7.10.1 Diatranz Otsuka Ltd Company Information
  57. 7.10.2 Diatranz Otsuka Ltd Business Overview
  58. 7.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio
  60. 7.10.5 Diatranz Otsuka Ltd Recent Developments
8 North America
  1. 8.1 North America Live Cell Encapsulation Revenue (2021-2032)
  2. 8.2 North America Live Cell Encapsulation Revenue by Type (2021-2032)
  3. 8.2.1 North America Live Cell Encapsulation Revenue by Type (2021-2026)
  4. 8.2.2 North America Live Cell Encapsulation Revenue by Type (2027-2032)
  5. 8.3 North America Live Cell Encapsulation Revenue Share by Type (2021-2032)
  6. 8.4 North America Live Cell Encapsulation Revenue by Application (2021-2032)
  7. 8.4.1 North America Live Cell Encapsulation Revenue by Application (2021-2026)
  8. 8.4.2 North America Live Cell Encapsulation Revenue by Application (2027-2032)
  9. 8.5 North America Live Cell Encapsulation Revenue Share by Application (2021-2032)
  10. 8.6 North America Live Cell Encapsulation Revenue by Country
  11. 8.6.1 North America Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Live Cell Encapsulation Revenue by Country (2021-2026)
  13. 8.6.3 North America Live Cell Encapsulation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Live Cell Encapsulation Revenue (2021-2032)
  2. 9.2 Europe Live Cell Encapsulation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Live Cell Encapsulation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Live Cell Encapsulation Revenue by Type (2027-2032)
  5. 9.3 Europe Live Cell Encapsulation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Live Cell Encapsulation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Live Cell Encapsulation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Live Cell Encapsulation Revenue by Application (2027-2032)
  9. 9.5 Europe Live Cell Encapsulation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Live Cell Encapsulation Revenue by Country
  11. 9.6.1 Europe Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Live Cell Encapsulation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Live Cell Encapsulation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Live Cell Encapsulation Revenue (2021-2032)
  2. 10.2 China Live Cell Encapsulation Revenue by Type (2021-2032)
  3. 10.2.1 China Live Cell Encapsulation Revenue by Type (2021-2026)
  4. 10.2.2 China Live Cell Encapsulation Revenue by Type (2027-2032)
  5. 10.3 China Live Cell Encapsulation Revenue Share by Type (2021-2032)
  6. 10.4 China Live Cell Encapsulation Revenue by Application (2021-2032)
  7. 10.4.1 China Live Cell Encapsulation Revenue by Application (2021-2026)
  8. 10.4.2 China Live Cell Encapsulation Revenue by Application (2027-2032)
  9. 10.5 China Live Cell Encapsulation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Live Cell Encapsulation Revenue (2021-2032)
  2. 11.2 Asia Live Cell Encapsulation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Live Cell Encapsulation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Live Cell Encapsulation Revenue by Type (2027-2032)
  5. 11.3 Asia Live Cell Encapsulation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Live Cell Encapsulation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Live Cell Encapsulation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Live Cell Encapsulation Revenue by Application (2027-2032)
  9. 11.5 Asia Live Cell Encapsulation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Live Cell Encapsulation Revenue by Country
  11. 11.6.1 Asia Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Live Cell Encapsulation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Live Cell Encapsulation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Live Cell Encapsulation Revenue (2021-2032)
  2. 12.2 SAMEA Live Cell Encapsulation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Live Cell Encapsulation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Live Cell Encapsulation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Live Cell Encapsulation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Live Cell Encapsulation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Live Cell Encapsulation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Live Cell Encapsulation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Live Cell Encapsulation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Live Cell Encapsulation Revenue by Country
  11. 12.6.1 SAMEA Live Cell Encapsulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Live Cell Encapsulation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Live Cell Encapsulation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst